Among the DEGs, ERBB3 overlapped in the PI3K/AKT and MAPK signaling pathways (Figure 4A), which is involved in the progression and metastasis of ovarian cancer and many other cancers (32–37). This evidence concerns the gene AKT1 and ovarian cancer.